艾哈迈德青光眼引流阀和莫尔滕诺植入物治疗新生血管性青光眼的长期疗效
Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma.
作者信息
Yalvac I S, Eksioglu U, Satana B, Duman S
机构信息
Department of Ophthalmology, Ankara Education and Research Hospital, Ankara, Turkey.
出版信息
Eye (Lond). 2007 Jan;21(1):65-70. doi: 10.1038/sj.eye.6702125. Epub 2005 Oct 7.
AIMS
To evaluate the surgical success results of Ahmed glaucoma valve (AGV) and Molteno single-plate implant (MSPI) in cases of neovascular glaucoma (NVG).
METHODS
Between May 1997 and May 2002, 38 of 38 NVG patients that underwent implantation of AGV and 27 eyes of 27 NVG patients that underwent MSPI (a total 65 eyes of 65 patients) included to the study.
RESULTS
The cumulative probabilities of success were 63.2% at 1 year, 56.2% at 2 years, 43.2% at 3 years, 37.8% at 4 years, and 25.2% at 5 years in AGV group whereas the cumulative probabilities of success were 37.0% at 1 year, 29.6% at 2 years, 29.6% at 3 years, 29.6% at 4 years, and 29.6% at 5 years in MSPI group (P=0.141). Preoperative visual acuity <2/200 (P=0.003), diagnosis of diabetes mellitius (P=0.050), and preoperative IOP>or=35 mmHg (P=0.038) were found to be poor prognostic factors for surgical success.
CONCLUSIONS
Both AGV and single plate MSPI were successful for early and intermediate-term of IOP control but in long term both implants were failed to achieve control of IOP in patients with NVG.
目的
评估艾哈迈德青光眼引流阀（AGV）和莫尔滕诺单盘植入物（MSPI）治疗新生血管性青光眼（NVG）的手术成功率。
方法
1997年5月至2002年5月期间，38例接受AGV植入的NVG患者中的38只眼以及27例接受MSPI植入的NVG患者中的27只眼（共65例患者的65只眼）纳入本研究。
结果
AGV组1年时的累积成功率为63.2%，2年时为56.2%，3年时为43.2%，4年时为37.8%，5年时为25.2%；而MSPI组1年时的累积成功率为37.0%，2年时为29.6%，3年时为29.6%，4年时为29.6%，5年时为29.6%（P = 0.141）。术前视力<2/200（P = 0.003）、糖尿病诊断（P = 0.050）以及术前眼压≥35 mmHg（P = 0.038）被发现是手术成功的不良预后因素。
结论
AGV和单盘MSPI在早期和中期眼压控制方面均取得成功，但长期来看，两种植入物均未能控制NVG患者的眼压。
Zotero 插件